Literature DB >> 18157043

Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA".

Hendrik van den Berg1, Herman M Kroon, Annelie Slaar, Pancras Hogendoorn.   

Abstract

INTRODUCTION: Data on childhood bone tumors are mainly confined to reports on malignant tumors or on institutional registries. Incidence figures on both benign and malignant bone tumors in childhood are lacking.
METHODS: From January 1999 to December 2003, 1474 newly diagnosed bone tumors in children up to 18 years were registered in Pathologisch Anatomisch Landelijk Geautomatiseerd Archief (the nationwide network and registry of histopathology and cytopathology in The Netherlands). Data provided were diagnosis, date of birth, age at diagnosis, and localization. For incidence calculations, data on age and sex in each year of investigation were obtained from the StatLine database of Statistics Netherlands (www.cbs.nl). RESULTS/
CONCLUSIONS: Incidence of pathology-proven bone tumors in children is low. Incidence of pathology-proven bone tumors in The Netherlands is 79.3 per 1,000,000. From the very first year of life, incidence increases from 3.9 per 1,000,000 to a peak at 13 to 15 years of 142.9 per 1,000,000. Osteochondromas are the most prevalent tumors, followed by aneurysmal bone cysts. The overall incidence is higher for male compared with female patients, mainly due to different frequencies found in aneurysmal bone cysts, Ewing sarcoma, and osteochondroma. Shifts in incidence differ among the various tumors. In infants, bone tumors are mainly chondromas and fibrous dysplasia, which both show a steady increase at older ages. Tumors most prevalent at older ages are osteochondromas, osteosarcomas, osteoid osteomas, and chondromas. A peak incidence at approximately the age of 10 is noted for solitary bone cysts, nonossifying fibromas, and osteoblastomas. Small children more often have localizations in the skull and facial bones. Comparison with literature data showed significant differences due to referral-based institutionally bias, whereas tumor registries only give data for specific tumor types.

Entities:  

Mesh:

Year:  2008        PMID: 18157043     DOI: 10.1097/BPO.0b013e3181558cb5

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  15 in total

1.  Surgical treatment of benign lesions and pathologic fractures of the proximal femur in children.

Authors:  Ryszard Tomaszewski; Erich Rutz; Johannes Mayr; Jerzy Dajka
Journal:  Arch Orthop Trauma Surg       Date:  2020-11-24       Impact factor: 3.067

Review 2.  High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.

Authors:  Lianne M Haveman; Roelof van Ewijk; Elvira C van Dalen; Willemijn B Breunis; Leontien Cm Kremer; Henk van den Berg; Uta Dirksen; Johannes Hm Merks
Journal:  Cochrane Database Syst Rev       Date:  2021-09-02

3.  Pattern of primary tumors and tumor-like lesions of bone in children: retrospective survey of biopsy results.

Authors:  Esra Akyüz Özkan; Ceren Canbey Göret; Zeynep Tuğba Özdemir; Serdar Yanık; Meryem Doğan; Aylin Gönültaş; Ayşe Neslin Akkoca
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.

Authors:  Ivy Jennes; Danielle de Jong; Kirsten Mees; Pancras C W Hogendoorn; Karoly Szuhai; Wim Wuyts
Journal:  BMC Med Genet       Date:  2011-06-26       Impact factor: 2.103

5.  Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation.

Authors:  Carlos E de Andrea; Malgorzata I Wiweger; Judith V M G Bovée; Salvatore Romeo; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2011-11-25       Impact factor: 4.064

Review 6.  High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma.

Authors:  Lianne M Haveman; Roelof van Ewijk; Elvira C van Dalen; Willemijn B Breunis; Leontien Cm Kremer; Henk van den Berg; Uta Dirksen; Johannes Hm Merks
Journal:  Cochrane Database Syst Rev       Date:  2021-09-02

7.  Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.

Authors:  Laurens G L Sand; Tessa Buckle; Fijs W B van Leeuwen; Willem E Corver; Alwine B Kruisselbrink; Aart G Jochemsen; Pancras C W Hogendoorn; Károly Szuhai
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

8.  A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes.

Authors:  Salvatore Romeo; Karoly Szuhai; Isao Nishimori; Marije Ijszenga; Pauline Wijers-Koster; Antonie H M Taminiau; Pancras C W Hogendoorn
Journal:  BMC Cancer       Date:  2009-11-10       Impact factor: 4.430

9.  Ewing sarcoma of the bone in children under 6 years of age.

Authors:  Maria Antonietta De Ioris; Arcangelo Prete; Raffaele Cozza; Marta Podda; Carla Manzitti; Andrea Pession; Elisabetta Schiavello; Benedetta Contoli; Rita Balter; Franca Fagioli; Gianni Bisogno; Loredana Amoroso; Franco Locatelli; Roberto Luksch
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.

Authors:  S U Lauvrak; E Munthe; S H Kresse; E W Stratford; H M Namløs; L A Meza-Zepeda; O Myklebost
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.